End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.31 CNY | -0.67% | -1.63% | -16.30% |
2023 | Yiling Pharmaceutical Gets Nod for China Clinical Trial of Tracheobronchitis Drug | MT |
2023 | Yiling Pharmaceutical's Lianhua Qingke Tablets Gets Nod to Become Over-the-Counter Drug; Shares Up 4% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.30% | 4.46B | |
+40.86% | 6.18B | |
-9.93% | 3.15B | |
-1.58% | 3.01B | |
-1.70% | 2.55B | |
+37.23% | 1.83B | |
-12.78% | 1.59B | |
+1.02% | 1.66B | |
-12.97% | 1.53B | |
+36.02% | 1.4B |
- Stock Market
- Equities
- 002603 Stock
- News Shijiazhuang Yiling Pharmaceutical Co., Ltd.
- Shijiazhuang Yiling Pharmaceutical : Gets Philippines' Nod for Traditional Chinese Covid-19 Medication